Editor’s Note: Today’s post is by Steven Inchcoombe. He is chief publishing officer at Springer Nature, and he is a member of the Management Board and his responsibilities cover all the research publishing and editorial activities of Springer Nature, the services provided to its authors, peer-reviewers, editors and societies, the experience of its customers when using its products and publishing platforms, and its Open Access and Open Research activities. Previously, Inchcoombe Steven was head of house and CEO at Nature Publishing Group (NPG) and Palgrave Macmillan (PM).
In January 2005, a paper was published in the Journal of Biomedical Science. “T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression” explored whether stem cells could be transplanted into other humans without the immune system (i.e., white blood cells) recognizing them as “foreign” and stimulating an immune response. An important study in its own right, having been cited over 400 times, what makes this paper even more notable for us at Springer Nature is that it marks the start of the one million immediately and fully open access (OA) primary research and review articles that we have published and are able to analyze.
These articles cover all academic disciplines and range from those which provide groundbreaking research to that which adds quietly but importantly to the academic literature and supports the development of further research. And, as research shows that articles published OA have increased impact, usage and reach, authors have also benefited.
Please select this link to read the complete article from The Scholarly Kitchen.